Trial finds adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA studypublishedinClinical Cancer Researchfound that in patients with unresectable, locally advanced

Updated on: November 30,2024

Trial finds adding immunotherapy to neoadjuvant chemoradiation may improve outcomes in esophageal cancer

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA studypublishedinClinical Cancer Researchfound that in patients with unresectable, locally advanced

Updated on:November 30,2024

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t

Updated on: January 10,2024

Existing drug shows promise treating most prevalent type of lung cancer

byUniversity of KentuckyCZT binds to SRC. A. CZT binding (dashed circle) to SRC. CZT binds near the C-terminal domain of SRC and may disrupt the inactive state by preventing phosphorylation on t

Updated on:January 10,2024

Researchers discover marker that may show when a type of skin cancer is preparing to metastasize

by Center for Genomic RegulationFrom left to right: Noemí Haro, Óscar Pozo, Inma Hernández-Muñoz, Evelyn Andrades, Paloma Torres & Ramon Pujol. Credit: Hospital de Mar/IMIMCells that form cutaneou

Updated on: February 20,2024

Researchers discover marker that may show when a type of skin cancer is preparing to metastasize

by Center for Genomic RegulationFrom left to right: Noemí Haro, Óscar Pozo, Inma Hernández-Muñoz, Evelyn Andrades, Paloma Torres & Ramon Pujol. Credit: Hospital de Mar/IMIMCells that form cutaneou

Updated on:February 20,2024

As patients live longer, new criteria needed for prostate cancer trials

JANUARY 26, 2024by Olivia Dimmer,Northwestern UniversityKaplan-Meier curves for (A) OS and rPFS and (B) OS and cPFS. cPFS=clinical progression-free survival; OS=overall survival; rPFS=radiograph

Updated on: March 25,2024

As patients live longer, new criteria needed for prostate cancer trials

JANUARY 26, 2024by Olivia Dimmer,Northwestern UniversityKaplan-Meier curves for (A) OS and rPFS and (B) OS and cPFS. cPFS=clinical progression-free survival; OS=overall survival; rPFS=radiograph

Updated on:March 25,2024

How conquering a rare leukemia in children revolutionized cancer care for millions

by Marie McculloughFifty years ago, children with an aggressive form of leukemia went from diagnosis to death in a few months, as the disease rampaged through their lymph nodes, spleens, livers, and n

Updated on: March 01,2024

How conquering a rare leukemia in children revolutionized cancer care for millions

by Marie McculloughFifty years ago, children with an aggressive form of leukemia went from diagnosis to death in a few months, as the disease rampaged through their lymph nodes, spleens, livers, and n

Updated on:March 01,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on: July 08,2024

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Updated on:July 08,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on: January 16,2024

Research suggests commonly used prostate cancer treatment rewires engine of prostate tumors

byUniversity of MichiganIn three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androge

Updated on:January 16,2024

Secret vulnerabilities of cancer's 'Death Star' protein revealed

byCenter for Genomic RegulationA three-dimensional image showing the human protein KRAS (blue) interacting with RAF1 (yellow), one of its main partners. The blue-to-red colour gradient indicates

Updated on: December 30,2023

Secret vulnerabilities of cancer's 'Death Star' protein revealed

byCenter for Genomic RegulationA three-dimensional image showing the human protein KRAS (blue) interacting with RAF1 (yellow), one of its main partners. The blue-to-red colour gradient indicates

Updated on:December 30,2023

Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAn accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstructi

Updated on: October 22,2024

Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction

byAmerican Society for Radiation OncologyCredit: Unsplash/CC0 Public DomainAn accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstructi

Updated on:October 22,2024

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for

Updated on: January 04,2024

Dual checkpoint inhibitor blockade shows promise as first-line and salvage therapy for Merkel cell carcinoma patients

byH. Lee Moffitt Cancer Center & Research InstituteMicrograph of a lung primary small cell carcinoma, a type of carcinoma. Credit: WikipediaMerkel cell carcinoma is a rare but aggressive for

Updated on:January 04,2024

PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising pr

Updated on: February 18,2024

PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer

by University of California, Los AngelesCredit: Unsplash/CC0 Public DomainA UCLA-led study has found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising pr

Updated on:February 18,2024

New imaging detects deadly lung and prostate cancers, may improve treatment

by Jim Stallard,Memorial Sloan Kettering Cancer CenterA new imaging technology developed in the laboratories of Dr. Jason Lewis and Dr. Charles Rudin could improve detection and treatment of cer

Updated on: July 08,2024

New imaging detects deadly lung and prostate cancers, may improve treatment

by Jim Stallard,Memorial Sloan Kettering Cancer CenterA new imaging technology developed in the laboratories of Dr. Jason Lewis and Dr. Charles Rudin could improve detection and treatment of cer

Updated on:July 08,2024